New Clot-Busting device tested for lung emergency
NCT ID NCT06189313
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called the Cleaner Pro Thrombectomy System, which is threaded through a blood vessel to suction out clots in the lungs of people with acute pulmonary embolism. The trial aims to see if the device safely reduces heart strain and avoids major complications. It plans to enroll 125 adults with recent clot symptoms and evidence of heart strain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cleaner Pro Thrombectomy System (a catheter-based device to remove blood clots)
What this could lead to
If successful, this device could offer a new way to quickly remove dangerous clots from the lungs, potentially reducing heart strain and improving outcomes for people with acute pulmonary embolism.
What could go wrong
This trial is currently suspended, and it is still early—results may not confirm the device is safe or effective. Risks include bleeding, vessel injury, or other serious complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ascension St. John Jane Phillips Medical Center
Bartlesville, Oklahoma, 74006, United States
-
Ascension St. Vincent Hospital
Indianapolis, Indiana, 46260, United States
-
BayCare Health System
Tampa, Florida, 33607, United States
-
Baylor Scott & White The Heart Hospital - Plano
Plano, Texas, 75093, United States
-
Baylor Scott and White Heart and Vascular Hospital - Dallas
Dallas, Texas, 75226, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Medstar Health Research Institute
Washington D.C., District of Columbia, 20010, United States
-
Promedica Toledo Hospital
Toledo, Ohio, 43606, United States
-
UMass Chan Medical School
Worcester, Massachusetts, 01655, United States
-
University Medical Center of Southern Nevada
Las Vegas, Nevada, 89102, United States
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States